Skip to main content
NIH funding notice RFA-AG-24-039

Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)

Closed on November 2, 2023.

Posted
July 5, 2023
Close date
November 2, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$1,011,183
$2,022,365 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. UNIVERSITY OF PENNSYLVANIA1

Most frequent study sections

  1. Special Emphasis Panel (ZAG1 ZIJ-2 (M1))2
2 awards under RFA-AG-24-039 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024Development, Validation, and Harmonization of Methods for Collection and Measurement of NAD+ and Related Metabolites: Application to a Randomized Trial of Patients Undergoing Coronary Artery Bypass1U01AG089040-01Bhasin, ShalenderGardell, Stephen JamesLeaf, David EvanBRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $1,020,661Study section ZAG1
FY2024Validation of NAD+ measurements for human clinical studies: multi-method inter-laboratory standardization1U01AG089107-01Baur, Joseph A.Mesaros, A. ClementinaReddy, RavinderUNIVERSITY OF PENNSYLVANIA, PAFirst-year cost $1,001,704Study section ZAG1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-AG-24-039: Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required) | ScienceDex | ConductScience